IP vs PHAT
International Paper (IP) versus Phathom Pharmaceuticals Inc (PHAT) — a side-by-side from cached financials, not a winner call.
International Paper (IP) is a packaging & containers company listed on US.
Phathom Pharmaceuticals Inc (PHAT) is a biotechnology company listed on US.
IP does not have a complete income-statement cache yet.
Latest reported PHAT revenue for 2024-12-31 was $55.3M. Net income was -$334.3M. Revenue was up 8001.5% from 2023-12-31 to 2024-12-31. PHAT currently screens at market cap $622.7M.
IP currently screens at market cap $26.62B and trailing P/E 43.1. PHAT currently screens at market cap $622.7M.
Not investment advice. Open the IP and PHAT stock pages for the full models.
Not investment advice.